Neuroprotective evaluation of three source plants of Rasna in experimental models of focal cerebral ischemia
Loading...
Date
item.page.authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Rasna source plants such as Pluchea lanceolata, Alpinia galanga and
newlineVanda roxburghii are mentioned in Ayurveda for the treatment of pain,
newlineindigestion, gout, cough, inflammation, arthritis, sciatica and neurological
newlinedisorders. According to Ayurveda, Rasna is considered as Agrya Dravya
newline(supreme drugs) for the management of any neurodegenerative conditions as
newlinethey are considered Vrushya and Vatahara. Vrushya means not only
newlineaphrodisiac but also depicts corrections of Saptha Dathu from rasa to Shukra.
newlineIn case of neuro degeneration, almost all seven Dathus (elements) are going
newlineto face the insult of virulent vatha and hence potent Rasayana /Vrushya
newlineDravya is required to be used in this condition. Rasna source drugs are being
newlineused in more than 120 herbal formulations for the treatment of chronicand
newlineacute illness. Some of the important formulations are Rasna erandadi
newlinekashaya, Rasna saptaka kashaya, Rasnadi guggulu, Maharasnadi kashaya,
newlineDadhika gritha and Rasnadi choorna. However, there is no experimental basis
newlinefor its therapeutic action in cerebral ischemic and cognitive impairment
newlinecondition. In the present study, investigations were done to determine if
newlinehydroalcoholic extract of Pluchea lanceolata (HAPL), Alpinia galanga (HAAG)
newlineand Vanda roxburghii (HAVR) could exert neuroprotection against experimental focal cerebral ischemia in rats by using histological, biochemical
newlineand cognitive assessment studies.
newline